SIRT6 and neoplasm: In diffuse large B-cell lymphoma cells, knockdown of SIRT6 increased sensitivity to chemotherapy, apoptosis rates, dysfunctional cell proliferation, and cell cycle arrest between the G2 and M phases, reflecting the tumor-promoting activity of SIRT6 (133).